| Abstract: | Advances in biotechnology make possible many things which even a few years ago would have seemed unimaginable. However, the steady advance of biotechnological innovation raises difficult questions for ethicists and regulators. In the thirty‐fourth Chorley Lecture Noelle Lenoir analyses the European response to these challenges and calls upon European leaders to honour their commitment to human dignity and to give leadership in the emergent fields of embryo research, cloning and genetic enhancement. |
